Fact CheckerSign in

NCT04542772Completed

Mirror Therapy Education for Acute Stroke Patients

Effectiveness of Patient Education on Mirror Therapy to Improve Upper Extremity Function in Acute Stroke Patients

Source: ClinicalTrials.gov · Last updated 5 Oct 2026

Brief summary (registry, in English)

In Canada, the number of stroke survivors is equivalent to the size of one of the four Atlantic Provinces. The incident rate of stroke has been increasing steadily since 1995. The majority of the stroke survivors lose upper extremity function, resulting in diminished activities of daily living (ADL). Many therapeutic interventions are recommended to improve upper extremity function or ADLs of stroke survivors, however, Mirror Therapy (MT), inexpensive intervention, can be self-administered by stroke survivors with intact cognition. Thus, the research question is whether a self-administered MT technique improves acute stroke patients' upper extremity motor function and recovery?

Status (registry)
Completed
Study type
Interventional
Enrollment
20 (actual)
First submitted
26 Aug 2020
Start date
4 Jul 2022
Primary completion date
3 May 2024
Lead sponsor
Health Sciences North Research Institute
Diseases
Stroke
NCT number
NCT04542772

What you commit to

  • Study type: Interventional
  • Participants enrolled: 20
  • From 4 Jul 2022 to the primary completion date, 3 May 2024
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Recurrent/ chronic stroke

Other

  • Medical instability
  • Lack of motivation
  • Recent upper extremity musculoskeletal injuries with movement restrictions
  • Receptive or global aphasia
  • Delirium
  • Unilateral neglect
  • Visual field deficiency.

Who the study is looking for

  • Admitted with diagnosis of stroke with onset within two weeks
  • Medically stable
  • Able to follow directions
  • No severe cognitive impairments that could interfere with patient participation
  • Consent to treatment by patient
  • Alpha-Functional Independence Measure (Alpha-FIM) score of \> 40

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Health Sciences North
Coordinator of this site? Confirm its status
Greater SudburyCanadaUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.